18.48
Schlusskurs vom Vortag:
$18.49
Offen:
$18.22
24-Stunden-Volumen:
362.52K
Relative Volume:
0.48
Marktkapitalisierung:
$938.91M
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-6.8699
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
+4.88%
1M Leistung:
-3.14%
6M Leistung:
-17.46%
1J Leistung:
+144.44%
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Vergleichen Sie CDNA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CDNA
Caredx Inc
|
18.48 | 938.91M | 312.78M | -143.56M | 1.22M | -2.69 |
![]()
TMO
Thermo Fisher Scientific Inc
|
424.24 | 159.25B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
197.14 | 132.37B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
437.44 | 32.95B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
106.28 | 28.58B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
150.28 | 24.90B | 15.41B | 1.37B | 2.11B | 7.50 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
2022-04-25 | Eingeleitet | Stephens | Overweight |
2021-07-20 | Fortgesetzt | BTIG Research | Buy |
2021-06-03 | Eingeleitet | Goldman | Buy |
2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
2020-06-26 | Eingeleitet | BTIG Research | Buy |
2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2019-02-15 | Eingeleitet | Jefferies | Buy |
2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
2016-06-14 | Bestätigt | Mizuho | Buy |
2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2015-09-25 | Eingeleitet | Craig Hallum | Buy |
2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
Press Release Distribution & PR Platform - ACCESS Newswire
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting - BioSpace
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting | CDNA Stock News - GuruFocus
CareDx, Inc (NASDAQ:CDNA) Stake Reduced by LPL Financial LLC - Defense World
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News - GuruFocus
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Eagle-Tribune
Lobbying Update: $50,000 of CAREDX INC. lobbying was just disclosed - Nasdaq
CareDx Officer Sells Shares to Satisfy Tax Obligations - TradingView
CareDx's secretary and general counsel sells shares worth $16,373 By Investing.com - Investing.com India
CareDx’s secretary and general counsel sells shares worth $16,373 - Investing.com Australia
CareDx's secretary and general counsel sells shares worth $16,373 - Investing.com
CareDx CFO Abhishek Jain sells shares worth $4,695 - Investing.com
Healthcare Tech Pioneer CareDx Set to Unveil Q1 2025 Performance Data - Stock Titan
CareDx to Report First Quarter 2025 Financial Results - The Joplin Globe
Prudential Financial Inc. Purchases 103,862 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx CFO secures new severance agreement terms - Investing.com Australia
CareDx CFO secures new severance agreement terms By Investing.com - Investing.com South Africa
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - Business Wire
CareDx Updates CFO Severance Agreement Amid Leadership Changes - TipRanks
CareDx Inc (CDNA) Shares Gap Down to $18.22 on Mar 26 - GuruFocus
CareDx Releases Two Expanded Indications for AlloSure Testing Services - Medical Product Outsourcing
SHAREHOLDER ALERT: Kaskela Law LLC Announces Class Action - GlobeNewswire
Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra
Trend Tracker for (CDNA) - news.stocktradersdaily.com
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta - Benzinga
CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - PR Newswire
CareDx Launches Two Expanded Indications for AlloSure Testing Services - Diagnostic and Interventional Cardiology
CareDx, Inc (NASDAQ:CDNA) Shares Bought by US Bancorp DE - Defense World
CareDx: Some Litigation Clouds Have Cleared - Seeking Alpha
CareDx director George Bickerstaff sells $367,102 in common stock - Investing.com India
CareDx Director Makes Significant Stock Sale! - TipRanks
CareDx director George Bickerstaff sells $367,102 in common stock By Investing.com - Investing.com UK
Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem - simplywall.st
Major Breakthrough: CareDx AlloSure Now Covers Infant Heart and Dual-Organ Transplant Testing - Stock Titan
Principal Financial Group Inc. Has $406,000 Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance
HC Wainwright Has Negative Estimate for CareDx Q1 Earnings - Defense World
(CDNA) On The My Stocks Page - news.stocktradersdaily.com
Rhumbline Advisers Boosts Stake in CareDx, Inc (NASDAQ:CDNA) - Defense World
New York State Common Retirement Fund Sells 15,584 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx (NASDAQ:CDNA) Trading Down 7.9% Following Analyst Downgrade - Defense World
CareDx stock price target cut to $25 at H.C. Wainwright By Investing.com - Investing.com Canada
CareDx (NASDAQ:CDNA) Price Target Cut to $25.00 by Analysts at HC Wainwright - Defense World
CareDx stock price target cut to $25 at H.C. Wainwright - Investing.com
Where CareDx Stands With Analysts - Benzinga
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):